X-linked Retinoschisis Research
X-linked retinoschisis natural history studies
We are enrolling qualified patients with x-linked retinoschisis in order to measure disease progression in a group of patients with this disease.
X-linked retinoschisis treatment trials
We are studying the safety and efficacy of a new drug treatment for patients ≥ 18 years of age with x-linked retinoschisis. The goal of this study is to reduce retinal splitting and visual loss
In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.
If you have a question related to x-linked retinoschisis, please contact us at 214-363-3911.
Related ArticlesClinical Center of Innovation for Age-Related Macular Degeneration Retina Foundation CEO Shares Fundraising Goals to Preserve and Save Vision Three Patents Awarded for Retina Foundation’s Two-Layer Ocular Implant in Japan, Europe and the United States Retina Foundation Has Eye on $1 Million Goal for Annual Visionary Luncheon Retina Foundation Completes $3.7M Capital Campaign